Aneurysmal subarachnoid haemorrhage is a neurological syndrome with complex systemic
complications. The rupture of an intracranial aneurysm leads to the acute extravasation of …

Objective To report the ESICM consensus and clinical practice recommendations on fluid
therapy in neurointensive care patients. Design A consensus committee comprising 22 …

Cerebral vasospasm is a prolonged but reversible narrowing of cerebral arteries beginning
days after subarachnoid hemorrhage. Progression to cerebral ischemia is tied mostly to …

Background and Purpose—Patients are classically at risk of delayed cerebral ischemia
(DCI) after aneurysmal subarachnoid hemorrhage. We validated a grading scale—the …

Delayed cerebral ischemia (DCI) is the most feared complication of aneurysmal
subarachnoid hemorrhage (aSAH). It increases the mortality and morbidity associated with …

Subarachnoid hemorrhage (SAH) is a devastating neurological disorder. Patients with
aneurysmal SAH develop secondary complications that are important causes of morbidity …

Background and Purpose: Delayed cerebral ischemia (DCI) is the most important cause for
a poor clinical outcome after a subarachnoid hemorrhage. The aim of this study was to …

Subarachnoid hemorrhage (SAH) is a life‐threatening condition, and although its two main
complications—cerebral vasospasm (CVS)/delayed cerebral ischemia (DCI) and early brain …

The leading cause of morbidity and mortality after surviving the rupture of an intracranial
aneurysm is delayed cerebral ischaemia (DCI). We present an update of recent literature on …

Background and Purpose—The results of previous studies suggest that early goal-directed
fluid therapy (EGDT) reduces delayed cerebral ischemia (DCI) after aneurysmal …